RxDoctor Payments Data

Charles Limb, MD

Otolaryngology · San Francisco, CANPI 1780629717

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (34.4%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Med-el Corporation accounts for 79.1% of it on its own, with 8 other manufacturers making up the rest. Among otolaryngology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,468in general payments, 2019–2025

Across 65 payments — averaging $191.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Med-el Corporation$10K
  • Cochlear Americas$1K
  • Advanced Bionics, LLC$650
  • Iotamotion, Inc.$308
  • Oticon Medical, LLC$200
  • Stryker$189
  • plus $247 from 3 others
$1,510,694in research payments, 2019–2025

Across 42 payments — averaging $35,969 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Med-el Corporation$1.5M
  • Advanced Bionics, LLC$50K
  • Cochlear Americas$3K

What the payments were for

  • Speaking & faculty fees$3,08625%
  • Travel & lodging$3,40227%
  • Food & beverage$4,29534%
  • Education$5855%
  • Other$1,1009%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Med-el Corporation34$9,866
Cochlear Americas14$1,007
Advanced Bionics, LLC8$650
Iotamotion, Inc.2$308
Oticon Medical, LLC1$200
Stryker3$189
Amgen1$154
Integra Lifesciences Corporation1$51
Smith+Nephew1$42

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,468 in reported general payments places this provider in the 90th percentile of 1,021 otolaryngology providers in California.

See all otolaryngology providers in California

Medicare billing

Part B allowed, 2024
$79,013
Medicare patients
236
Services billed
513

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Emgality PenGalcanezumab-Gnlm13$19,709
Aimovig AutoinjectorErenumab-Aooe16$15,604
Nortriptyline Hcl29$857
Ofloxacin14$757
Acetazolamide24$751
Ipratropium Bromide11$327
Venlafaxine Hcl ErVenlafaxine Hcl28$290
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid30$270
Prednisone12$118
Clonazepam21$106
Methylprednisolone18$93

Paid to pharmacies, not to this prescriber.

Other otolaryngology in San Francisco

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →